Henric Bjarke

2019

In 2019, Henric Bjarke earned a total compensation of $590.8K as Senior Vice President and Chief Operating Officer at Inozyme Pharma.

Compensation breakdown

Bonus$99,201
Option Awards$141,388
Salary$350,200
Total$590,789

Bjarke received $350.2K in salary, accounting for 59% of the total pay in 2019.

Bjarke also received $99.2K in bonus and $141.4K in option awards.

Rankings

In 2019, Henric Bjarke's compensation ranked 11,253rd out of 13,971 executives tracked by ExecPay. In other words, Bjarke earned more than 19.5% of executives.

ClassificationRankingPercentile
All
11,253
out of 13,971
20th
Division
Manufacturing
4,557
out of 5,701
20th
Major group
Chemicals And Allied Products
1,793
out of 2,200
19th
Industry group
Drugs
1,542
out of 1,886
18th
Industry
Pharmaceutical Preparations
1,142
out of 1,398
18th
Source: SEC filing on April 27, 2021.

Bjarke's colleagues

We found one more compensation record of an executive who worked with Henric Bjarke at Inozyme Pharma in 2019.

2019

Axel Bolte

Inozyme Pharma

Chief Executive Officer

News

You may also like